[EN] AZIRIDINYL AND AMINO DIMERIC NAPHTHOQUINONE COMPOUNDS AND USE FOR ACUTE MYELOID LEUKEMIA [FR] COMPOSÉS DE NAPHTOQUINONE D'AZIRIDINYLE ET D'AMINO DIMÈRE ET LEUR UTILISATION POUR LA LEUCÉMIE MYÉLOÏDE AIGUË
Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone – A novel class of compounds with potent activity against acute myeloid leukemia cells
作者:Brandon A. Carter-Cooper、Steven Fletcher、Dana Ferraris、Eun Yong Choi、Dahlia Kronfli、Smaraki Dash、Phuc Truong、Edward A. Sausville、Rena G. Lapidus、Ashkan Emadi
DOI:10.1016/j.bmcl.2016.11.045
日期:2017.1
The synthesis, characterization and antileukemic activity of rationally designed amino dimeric naphthoquinone (BiQ) possessing aziridine as alkylating moiety is described. Bis-aziridinyl BiQ decreased proliferation of acute myeloid leukemia (AML) cell lines and primary cells from patients, and exhibited potent (nanomolar) inhibition of colony formation and overall cell survival in AML cells. Effective
AZIRIDINYL AND AMINO DIMERIC NAPHTHOQUINONE COMPOUNDS AND USE FOR ACUTE MYELOID LEUKEMIA
申请人:University of Maryland, Baltimore
公开号:US20200283417A1
公开(公告)日:2020-09-10
The invention relates to new amino dimeric naphthoquinone compounds with antileukemic activity. Compounds of the invention demonstrated increased aqueous solubility compared to previously available dimeric naphthoquinones and potent nanomolar inhibition of cell survival in AML cells. Preferred compounds contained an aziridine or a secondary amino alcohol pharmacophore.